BNP Paribas Aktienanleihe MUV2 29.../ DE000PC7FK94 /
23/05/2024 10:11:38 | Chg.-0.14 | Bid13:11:09 | Demandez à13:11:09 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
100.02EUR | -0.14% | 99.95 Bid taille: 300,000 |
100.05 Ask la taille: 300,000 |
MUENCH.RUECKVERS.VNA... | 400.00 EUR | 29/12/2025 | Call |
GlobeNewswire
13:17
CAE, Inc. Falls Over 13% at Open on Impairment Charges, BFA Law Encourages Investors to Contact the ...
GlobeNewswire
13:03
Unicycive Therapeutics to Participate in a Fireside Chat at the Lytham Partners Spring 2024 Investor...
GlobeNewswire
13:00
atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors
GlobeNewswire
13:00
OneMedNet Reports Greater than Five-Fold Expansion of iRWD™ Network and Platform
GlobeNewswire
13:00
Sono-Tek Announces Fiscal Year 2024 Results with Record-Breaking Revenue and Record YOY Backlog
GlobeNewswire
13:00
Hydreight Technologies through its associated Medical network now offer Tirzepatide to Product Offer...
GlobeNewswire
13:00
Leading Proxy Advisory Firm ISS Recommends that Mayfair Gold Shareholders Vote FOR All Company Nomin...
GlobeNewswire
13:00
TFF Pharmaceuticals and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA...
GlobeNewswire
13:00
Pyro Green-Gas Signs Contracts Totaling $1.3 Million with Global Steel Company to Desulphurize Coke ...
GlobeNewswire
13:00
Immersive Fishing and Boating Sim ‘Ships at Sea’ from Misc Games Available Now in PC Early Access
GlobeNewswire
13:00
Sandy Spring Bancorp’s Board of Directors Appoints Charles S. Cullum Chief Financial Officer
GlobeNewswire
13:00
Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Pr...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page